Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target.
Saved in:
| Title: | Diversity of extracellular HSP70 in cancer: advancing from a molecular biomarker to a novel therapeutic target. |
|---|---|
| Authors: | Hu B; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Liu G; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China., Zhao K; Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Western China Collaborative Innovation Center for Early Diagnosis and Multidisciplinary Therapy of Lung Cancer, Chengdu, Sichuan, China., Zhang G; Faculty of Dentistry, The University of Hong Kong, Hong Kong, Hong Kong SAR, China. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Apr 05; Vol. 14, pp. 1388999. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
